(Q33409364)
Statements
1 reference
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer (English)
1 reference
Henry Pitot
1 reference
Charles Erlichman
1 reference
Joel Picus
1 reference
Winston Tan
1 reference
Ulka Vaishampayan
1 reference
Roberto Pili
1 reference
Rui Qin
1 reference
P J Flynn
1 reference
Michael Millward
1 reference
Wing Ming Ho
1 reference
Kiersten M Miles
1 reference
26 July 2013
1 reference
1 reference
11
1 reference
477-483
1 reference
Identifiers
1 reference
1 reference
1 reference